Holen Sie sich die Stockscreener-App
2.40
0.84%
0.02
Schlusskurs vom Vortag:
$2.38
Offen:
$2.41
24-Stunden-Volumen:
27,900
Relative Volume:
1.01
Marktkapitalisierung:
$16.89M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-7.72M
KGV:
-0.9093
EPS:
-2.6394
Netto-Cashflow:
$-6.25M
1W Leistung:
+7.38%
1M Leistung:
-1.23%
6M Leistung:
-1.23%
1J Leistung:
-46.07%
1-Tages-Spanne:
$2.33
$2.45
1-Wochen-Bereich:
$2.22
$2.48
52-Wochen-Spanne:
$1.55
$5.00
Edesa Biotech Inc Stock (EDSA) Company Profile
Firmenname
Edesa Biotech Inc
Sektor
Branche
Telefon
(905) 475-1234
Adresse
100 SPY COURT, MARKHAM, ON
Vergleichen Sie EDSA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
EDSA
Edesa Biotech Inc
|
2.40 | 15.99M | 0 | -7.72M | -6.25M | -2.6394 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Edesa Biotech Inc Aktie (EDSA) Neueste Nachrichten
Is Edesa Biotech Inc. stock bottoming outEarnings Performance Report & Risk Controlled Swing Alerts - Newser
Can technical indicators confirm Edesa Biotech Inc.’s reversalJuly 2025 PostEarnings & Reliable Momentum Entry Alerts - Newser
Understanding Edesa Biotech Inc.’s price movementQuarterly Trade Review & Capital Efficient Trade Techniques - Newser
Statistical indicators supporting Edesa Biotech Inc.’s strengthJuly 2025 Review & Weekly Stock Performance Updates - Newser
Risk vs reward if holding onto Edesa Biotech Inc.New Guidance & Verified Momentum Stock Watchlist - Newser
Edesa Biotech Inc. stock trend outlook and recovery pathJuly 2025 Opening Moves & Stock Market Timing Techniques - Newser
Detecting support and resistance levels for Edesa Biotech Inc.Portfolio Value Report & Safe Entry Trade Signal Reports - Newser
Top chart patterns to watch in Edesa Biotech Inc.Weekly Investment Recap & Risk Controlled Daily Trade Plans - Newser
Price action breakdown for Edesa Biotech Inc.Weekly Trade Recap & Fast Entry High Yield Tips - Newser
Live Scanner Shows Breakout on Edesa Biotech Inc.July 2025 Update & Fast Moving Trade Plans - sundaytimes.kr
How Resilient Is Edesa Biotech Inc. Stock During Economic DownturnsTrade Volume Summary & Daily Stock Trend Watchlist - Newser
Zacks Small Cap Reduces Earnings Estimates for Edesa Biotech - Defense World
Tools to monitor Edesa Biotech Inc. recovery probability2025 EndofYear Setup & Expert Verified Movement Alerts - Newser
Edesa Biotech Inc. stock chart pattern explained2025 Retail Activity & Reliable Trade Execution Plans - Newser
How hedge fund analytics apply to Edesa Biotech Inc. stockTrade Risk Assessment & Consistent Growth Equity Picks - Newser
How to track smart money flows in Edesa Biotech Inc.Market Growth Review & Consistent Profit Focused Trading Strategies - Newser
Real time alert setup for Edesa Biotech Inc. performanceGold Moves & Free AI Powered Buy and Sell Recommendations - Newser
How sentiment analysis helps forecast Edesa Biotech Inc.Portfolio Return Report & Low Drawdown Trading Techniques - Newser
Is Edesa Biotech Inc. undervalued by DCF analysisQuarterly Earnings Summary & High Return Trade Guides - sundaytimes.kr
How to build a custom watchlist for Edesa Biotech Inc.Portfolio Risk Summary & Growth Focused Stock Reports - Newser
Why is Edesa Biotech Inc. stock going up2025 Valuation Update & Risk Controlled Swing Trade Alerts - thegnnews.com
Edesa Biotech Inc. Included in Top Momentum ScanMarket Risk Summary & Community Consensus Trade Signals - 선데이타임즈
Vitiligo Clinical Trial Pipeline Accelerates as 18+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight - GlobeNewswire Inc.
Edesa Biotech Inc. Earnings Report Breakdown: What Investors Should Know2025 Winners & Losers & Long-Term Growth Stock Strategies - Newser
EDSA: EB06 Manufacturing to be Completed by End of 2025… - Zacks Small Cap Research
Edesa Biotech Inc. Reaches Critical Trendline SupportWall Street Watch & Reliable Price Action Trade Plans - beatles.ru
Can momentum traders help lift Edesa Biotech Inc.Weekly Trade Summary & Free AI Powered Buy and Sell Recommendations - Newser
Edesa Biotech Posts Narrower Loss in Q3 - AOL.com
How Edesa Biotech Inc. stock performs during market volatilitySmart Trade Forecast Based on Neural Logic - Newser
Edesa Biotech: A Narrowing Loss and Strategic Focus Signal Growing Momentum in Dermatology Innovation - AInvest
Will Edesa Biotech Inc. stock go up soonStock Entry Point Planner with Volume Spike - Newser
Edesa Biotech's Strategic Reorientation and Financial Resilience: A Path to Dermatology Sector Growth - AInvest
Finanzdaten der Edesa Biotech Inc-Aktie (EDSA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.94%
1.72%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):